Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

London investment firm acquiring radiology vendor Intelerad for $500M-plus

Hg Capital has invested about $1 billion in the healthcare technology sector to date, including the Montreal, Quebec, imaging software provider.

Thumbnail

Partnership aims to bring AI imaging solutions to Africa

Oxipit, a Lithuania-based medical imaging solutions manufacturer, and Healthcare Konnect, a Swiss distribution company, have announced a new partnership focused on delivering AI imaging solutions to Nigeria.

Thumbnail

Hitachi launching imaging innovation hub in US, with AI a key focus

Located within its North American headquarters, the hub would pursue radiology-related research and development to create the next generation of diagnostic technology. 

Thumbnail

The problem with cardiac executive screening programs

Well-to-do individuals shell out thousands—and sometimes tens of thousands—of dollars for “executive” screening programs at top-ranked hospitals. But is that money really well-spent?

Massive drops in imaging reimbursement signal some private radiology practices ‘may be in jeopardy’

That’s according to a new analysis of Medicare Part B payment data, published in January’s Journal of the American College of Radiology

Thumbnail

Chuck Norris’ gadolinium lawsuit against Bracco dismissed

Norris filed the suit against the manufacturer in November 2017, alleging his wife Gena suffered severe side effects from the contrast agent. 

Thumbnail

Fresh off Hitachi deal, Fujifilm exploring $3B purchase of nuclear imaging supplier

The Tokyo-based camera giant is competing with two private equity firms in the bidding war for Curium, which produces radioactive tracers used in nuclear medicine. 

Thumbnail

Chuck Norris voluntarily abandons poisoning lawsuit against gadolinium manufacturer Bracco

The action star—famous for his portrayal of “Walker Texas Ranger”—first filed suit against the Italy-based company and several others in 2017.